• Home
  • Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance.

Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance.

Author List
Jansen JP, Kumar R, Carmeli Y
Publication
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/102292421
Publication Year
2009
PubMed ID
20667059
Publication Title
Jansen JP, Kumar R, Carmeli Y. Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance. Value Health. 2009 Mar-Apr; 12(2):234-44.